4.2 Article

Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin

期刊

PRIMARY CARE DIABETES
卷 4, 期 2, 页码 113-117

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.pcd.2010.04.001

关键词

Type 2 diabetes; DTSQ; IWQOL-Lite; Liraglutide; Treatment satisfaction

资金

  1. Novo Nordisk
  2. Novo Nordisk Inc.
  3. National Institute for Health Research [NF-SI-0508-10272] Funding Source: researchfish

向作者/读者索取更多资源

Patient-reported outcomes for liraglutide or glimepiride on metformin were investigated. Patients' treatment satisfaction on liraglutide was higher than with metformin alone and comparable with glimepiride + metformin. Patients perceived lower frequency of hypoglycaemia than glimepiride + metformin and lower frequency of hyperglycaemia than metformin. Impact of weight on quality of life did not differ. (C) 2010 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据